Dr. Iftikhar J. Kullo, MD

Dr. Kullo practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Kullo's NPI, 1104890581, was assigned on February 14, 2006. Dr. Kullo graduated from Government Medical College of Jammu and Kashmire in 1987. Dr. Kullo holds Minnesota license 37166.

Dr. Kullo's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Kullo's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. Dr. Kullo is also affiliated with Froedtert Hospital. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Kullo to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kullo practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kullo's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kullo is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Kullo is licensed in Minnesota.

Dmand AI lists aneurysm, atherosclerosis, circulation problems, congestive heart failure, coronary artery disease, heart attack and high cholesterol among the conditions Dr. Kullo treats.

CMS data shows 102 Medicare services from Dr. Kullo across 5 procedure codes in 2024, for 73 Medicare patients. Medicare paid $10,172 for them.

CMS counts 73 Medicare patients who saw Dr. Kullo in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kullo's median patient age at 66, with 53% women.

In 2024, Dr. Kullo wrote 238 Medicare Part D claims for 48 patients. 45% of them were for generic drugs. CMS names the drug for 206 of them, across 5 drugs with 11 or more claims each, at $98,644 in total drug cost. In 2023, CMS named 195 claims across 6 drugs.

Dr. Kullo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 261 papers to Dr. Kullo, published from 2005 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Genome-Wide Association Study, Polymorphism, Single Nucleotide and Electronic Health Records. Dr. Kullo has published most often in Genet Med. Dr. Kullo's most frequent co-authors are Gail P. Jarvik, MD, PhD, Hakon Hakonarson, MD and Joshua Charles Denny, MD, MS.

Dmand AI links Dr. Kullo to 2 clinical trials. Conditions studied include Coronary Disease, Hypercholesterolemia and Hyperlipidemias.

CMS Open Payments shows 39 general payments to Dr. Kullo from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 63% of the total. Pfizer Inc. paid the most, $85,211.

Dmand AI lists 10 awards for Dr. Kullo, most recently Young Investigator Award Finalist in 2012.

Dr. Kullo graduated from Government Medical College of Jammu and Kashmire in 1987. Dr. Kullo is a member of ACC.

Dr. Kullo is in network with 17 carriers, including Aetna, Elevance and Medica. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.